R&F Capital Advisors’s CME Group CME Stock Holding History

R&F Capital Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,583	Closed	-$759K	–	700
2016 Q4	$759K	Buy	+6,583	New	+$733K	0.27%	113

Other funds holding CME

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

R&F Capital Advisors's CME Position: Q1 2017 in Review

R&F Capital Advisors sold out of CME Group (CME) in Q1 2017, closing a stake of 6,583 shares — an estimated $759K sold.

R&F Capital Advisors first reported a position in CME in Q4 2016 and held it in 1 quarter. The position peaked at $759K in Q4 2016. 763 funds tracked by Wall St. Rank hold CME as of Q1 2017.

R&F Capital Advisors reported no remaining CME Group position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 6,583 CME Group shares in Q1 2017, an estimated $759K.
R&F Capital Advisors first reported a position in CME Group in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's CME Group position peaked at $759K in Q4 2016.
763 funds tracked by Wall St. Rank held CME Group as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.